2009 (3 POSTS)

Thompson CM, Grafstrom RC. 2009. Commentary: Mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma. Environ Health 8:53; doi: 10.1186/1476-069X-8-53.

View Abstract

Elespuru RK, Agarwal R, Atrakchi A, Bigger CAH, Heflich RH, Jagannath D, Levy DD…Robison TW, et al. 2009. Current and future application of genetic toxicity assays: The role and value of in vitro mammalian assays. Toxicol Sci 109(2):172-179; doi: 10.1093/toxsci/kfp067.

View Abstract

2008 (3 POSTS)

Kelsh MA, Alexander DD, Kalmes RM, Buffler PA. 2008. Personal use of hair dyes and risk of bladder cancer: A meta-analysis of epidemiologic data. Cancer Causes Control 19(6):549–558.

View Abstract

Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS. 2008. Low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis. Regul Toxicol Pharmacol 52(3):299–310.

View Abstract

Subramaniam RP, Chen C, Crump KS, Devoney D, Fox JF, Portier CJ, Schlosser PM, Thompson CM, White P. 2008. Uncertainties in biologically-based modeling of formaldehyde-induced respiratory cancer risk: Identification of key issues. Risk Analysis 28(4):907–923; doi: 10.1111/j.1539-6924.2008.01083.x.

View Abstract

2007 (5 POSTS)

Alexander DD, Kelsh MA, Mink PJ, Mandel JH, Basu R, Weingart W. 2007. A meta-analysis of occupational trichloroethylene exposure and liver cancer. Int Arch Occup Environ Health 81(2):127–143; doi: 10.1007/s00420-007-0201-4. PMID: 17492303.

View Abstract

Proctor DM, Gatto NM, Hong SJ, Allamneni KP. 2007. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment. Toxicol Sci 98(2):313–326; doi: 10.1093/toxsci/kfm075.

View Abstract

Buffler PA, Kelsh MA, Kalmes RL, Lau E, Chapman PC, Wood S, et al. 2007. A nested case-control study of brain tumors among employees at a petroleum exploration and extraction research facility. J Occup Environ Med 49(7):791–802; doi: 10.1097/JOM.0b013e318076b7bf. PMID: 17622853.

View Abstract

Lea IA, Jackson MA, Li X, Bailey S, Peddada SD, Dunnick JK. 2007. Genetic pathways and mutation profiles of human cancers: Site- and exposure-specific patterns. Carcinogenesis 28(9):1851–1858; doi: 10.1093/carcin/bgm176.

View Abstract

Teta MJ, Lau E, Sceurman BK, Wagner ME. 2007. Therapeutic radiation for lymphoma: Risk of malignant mesothelioma. Cancer 109(7):1432–1438; doi: 10.1002/cncr.22526.

View Abstract

2006 (7 POSTS)

Alexander DD, Mink PJ, Mandel JH, Kelsh MA. 2006. A meta-analysis of occupational trichloroethylene exposure and multiple myeloma or leukemia. Occup Med 56(7):485–493; doi: 10.1093/occmed/kql083. PMID: 16905622.

View Abstract

Mandel JH, Kelsh MA, Mink PJ, Alexander D, Kalmes RM, Weingart M, et al. 2006. Occupational trichloroethylene exposure and non-Hodgkins lymphoma: A meta-analysis and review. Occup Environ Med 63(9):597–607; doi: 10.1136/oem.2005.022418. PMID: 16644896.

View Abstract

David RM, Clewell HJ, Gentry PR, Covington TR, Morgott DA, Marino DJ. 2006. Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations. Regul Toxicol Pharmacol 45(1):55–65; doi: 10.1016/j.yrtph.2005.12.003.

View Abstract

Marino DJ, Clewell HJ, Gentry PR, Covington TR, Hack CE, David RM, Morgott DA. 2006. Revised assessment of cancer risk to dichloromethane: Part I Bayesian PBPK and dose-response modeling in mice. Regul Toxicol Pharmacol 45(1):44–54; doi: 10.1016/j.yrtph.2005.12.007.

View Abstract

Degregorio MW, Dingley KH, Wurz GT, Ubick E, Turteltaub KW. 2006. Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations. Cancer Chemother Pharmacol 57(3):335-342; doi: 10.1007/s00280-005-0060-1. PMID: 16047147.

View Abstract

Malfatti MA, Dingley KH, Nowell-Kadlubar S, Ubick EA, Mulakken N, Nelson D, Lang NP, et al. 2006. The urinary metabolite profile of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is predictive of colon DNA adducts after a low-dose exposure in humans. Cancer Res 66(21):10541–10547; doi: 10.1158/0008-5472.CAN-06-1573. PMID: 17079477.

View Abstract

Jackson MA, Lea I, Rashid A, Peddada SD, Dunnick JK. 2006. Genetic alterations in cancer knowledge system: Analysis of gene mutations in mouse and human liver and lung tumors. Toxicol Sci 90(2):400–418; doi: 10.1093/toxsci/kfj101.

View Abstract

2005 (1 POST)

Ebeler SE, Dingley KH, Ubick E, Abel S, Mitchell AE, Burns SA, et al. 2005. Animal models and analytical approaches for understanding the relationships between wine and cancer. Drugs Exp Clin Res 31(1):19–27. PMID: 15921026.

View Abstract

2004 (2 POSTS)

Warren DA, Kerger BD, Britt JK, James RC. 2004. Development of an oral cancer slope factor for Aroclor 1268. Regul Toxicol Pharmacol 40(1):42-53; doi: 10.1016/j.yrtph.2004.04.005.

View Abstract

Goodman M, Teta MJ, Hessel PA, Garabrandt DH, Craven VA, Scrafford CG, Kelsh MA. 2004. Mesothelioma and lung cancer among motor vehicle mechanics: A meta-analysis. Ann Occup Hyg 48(4):309–326; doi: 10.1093/annhyg/meh022. PMID: 15148053.

View Abstract